X-linked agammaglobulinemia (XLA) is a primary immunodeficiency caused by mutations in the gene for
Bruton tyrosine kinase (BTK) that result in the deficient development of B lymphocytes and
hypogammaglobulinemia. Because the disorder is uncommon, no single institution has had sufficient numbers of patients to develop a comprehensive clinical picture of the disorder. Accordingly, a national registry of United States residents with XLA was established in 1999 to provide an updated clinical view of the disorder in a large cohort of patients. A total of 201 patients were registered by 66 physicians. The estimated birth rate for the 10-year period of 1988-1997 was 1/379,000.
Infection was the most common initial clinical presentation (85%), followed by a positive family history (41%) and
neutropenia (11%). Although the average age of diagnosis was younger in patients with a positive family history (mean, 2.59 yr) than in patients with a negative family history (mean, 5.37 yr) (p < 0.001), only 34.5% of patients with a positive family history at the time of their birth were diagnosed before clinical symptoms developed-that is, based on family history alone. Seventy percent of patients had at least 1 episode of
otitis, 62% at least 1 episode of
pneumonia, 60% at least 1 episode of
sinusitis, 23% at least 1 episode of chronic/recurrent
diarrhea, 21% at least 1 episode of
conjunctivitis, 18% at least 1 episode of
pyoderma and/or
cellulitis, 11% at least 1 episode of
meningitis/
encephalitis, 10% at least 1 episode of
sepsis, 8% at least 1 episode of
septic arthritis, 6% at least 1 episode of
hepatitis, and 3% at least 1 episode of
osteomyelitis. Fourteen of 201 (6.9%) patients were dead at the time they were entered in the Registry. However, in a prospective 4 /4-year follow-up of living patients, only 3/80 (3.75%) patients died. Causes of death included disseminated
enterovirus infection (n = 6), pulmonary insufficiency (n = 5),
adenovirus infection (n = 1),
sepsis (n = 1), acquired immunodeficiency disease syndrome (
AIDS) (n = 1),
myocarditis (n = 1),
hepatitis (n = 2), and
stem cell transplantation (n = 1).